Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-24-022909

Director sold 5,000 shares at $57.26 ($286,300)

  • Director acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PARSHALL B LYNNE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-26 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $21.61 $108,050 25,600 D
2024-08-26 Sale : show line 2 in the form 10b5-1 −5,000 $57.26 $286,300 20,600 D
Open-market sales · 5,000 sh · avg $57.26 · $286,300

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-26 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −5,000 5,000 D
Loading xslF345X05/form4.xml…